HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Biotherapies for psoriasis: Options following the suspension of Raptiva?].

AuthorsF Aubin, H Bachelez, J-C Beani, P Berbis, M Beylot-Barry, V Descamps, L Dubertret, C Goujon, M Jeanmougin, M Le Maître, J-P Ortonne, C Paul, Psoriasis de la Société française de dermatologie
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 136 Issue 5 Pg. 399-401 (May 2009) ISSN: 0151-9638 [Print] France
Vernacular TitleLes biothérapies du psoriasis: quelle attitude après la suspension de commercialisation du Raptiva?
PMID19442793 (Publication Type: Editorial)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens
  • efalizumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens (therapeutic use)
  • Humans
  • Psoriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: